MCHX vs META
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MCHX exhibits severe financial distress as evidenced by a Piotroski F-Score of 1/9, indicating critical weakness in operational efficiency and financial health. Despite a clean balance sheet with very low debt (D/E 0.02) and adequate liquidity, the company is struggling with negative revenue growth (-9% YoY) and consistent net losses. The forward P/E of 149.00 suggests an extremely poor earnings outlook, and the technical trend is fully bearish. While one analyst maintains a high target price of $4.00, the fundamental data does not support such a valuation.
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
Compare Another Pair
Related Comparisons
MCHX vs META: Head-to-Head Comparison
This page compares Marchex, Inc. (MCHX) and Meta Platforms, Inc. (META) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.